Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform

← catalyst calendar

NCT03737149 · results posted

Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · None · Supportive care
Enrollment
6,559actual
Sites
30
Countries
Australia, Italy, Netherlands +1

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2018-10-22actualWhen the study began enrolling
Primary completion2025-04-15actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-04-15actualThe whole study's end, after follow-up
First posted2018-11-09actualWhen this record first appeared on the registry
Results posted2026-03-23actualWhen the sponsor posted results to the registry
Record updated2026-03-23actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Osteoarthritis, Knee
  • Osteoarthritis, Hip

Intervention

  • Other: mymobility with Apple Watch

Primary outcome

what the primary-completion date above is the date OF
Phase II (RCT): Readmissions
measured 30 Days

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol and Statistical Analysis Planposted 2022-02-14 · 974 KB · Prot_SAP_000.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed